Microbiological Testing/Measurement TRIZ Cases

A diagnostic method detects subclinical kidney rejection using TCL1A and AKR1C3 gene expression levels in blood samples.

Direct antibody binding to nucleosome-associated nucleotides bypasses invasive DNA extraction, reducing detection time and complexity.

Segmented PCR assays using local quality primers distinguish HpLVd from BCTV to resolve diagnostic accuracy limits.

Cultured vascular networks assess cancerization potential using body fluids, avoiding complex gene analysis.

Multiplexed nested PCR amplifies paired TCR alpha and beta chains from individual cells using barcoded chimeric primers.

A composite imaging method combines fluorescent protein detection with nucleic acid hybridization on a single biological sample section.

Photoactive probes replace optical tags with pH shifts to resolve detection accuracy and feature size limits.

Optimized permselective membranes prevent immunoglobulin permeation in glucose sensors, maintaining enzyme activity and extending operational life.

A photoactivated chemical bleaching method using a borate salt electron transfer agent to rapidly inactivate fluorescent dyes for multiplexed biological analysis.

Extracting cDNA sequences from lymphocytes to identify high-affinity monoclonal antibodies.

Ternary self-assembled monolayers on gold reduce pinhole defects and nonspecific adsorption, enabling single-copy nucleic acid detection in complex matrices.

Aldehyde releasing reagents convert cross-linked aldehydes into non-reactive forms to restore immunoreactivity in fixed tissue samples.

Multiplex assay compositions detect ALK, RET, and ROS1 fusion genes using specific primer sets and labeled probes.

Asymmetric adapters resolve sequence bias during amplification by enabling direct cDNA sequencing without exponential steps.

Nuclease-resistant detector oligos enable sensitive liquid-phase nucleic acid ligation assays without solid-phase immobilization.

Size profiling of urine cell-free DNA resolves low concentration variability to detect bladder cancer and kidney inflammation.

A single-culture in vitro method measures biliary excretion using hepatocytes forming bile canaliculi.

Serum ST2 and IL-33 measurement predicts mortality risk, resolving diagnostic uncertainty for patients with non-specific symptoms.

Stabilizing solution preserves protein stability and analyte concentration in small fecal samples, enabling multi-biomarker detection beyond hemoglobin.

A micro flow path with a fluid-impervious space and porous medium controls lateral liquid movement for assay testing.

Patsnap Eureka analyzes purified beta-glucuronidase blends that hydrolyze diverse glucuronide substrates through synergistic enzymatic action.

Specific oligonucleotide primers enable nested PCR amplification of HCV NS3 regions, resolving poor sensitivity caused by high genome variability.

A coupled enzyme assay measures meprin activity using an auxiliary enzyme and chromogenic substrate.

Analyzing plasma protein ratios alongside genotypes improves diagnostic accuracy while avoiding invasive cerebrospinal fluid collection.

Size control ladders assess FFPE nucleic acid quality, reducing fragmentation errors in genetic analysis.

Genetic analysis of GRIA1 gene mutations determines bovine ovum collection efficiency, resolving variability in superovulatory treatment outcomes.

Predictive models analyze blood biomarker expression levels to generate quantitative scores indicating multiple sclerosis disease activity.